Medicure Inc.

Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat which is a glycoprotein GP IIb/IIIa receptor antagonist, is used for the treatment of acute coronary syndrome including unstable angina. The firm derives the majority of its revenue geographically from the United States.